Arcturus Therapeutics Holdings Inc (ARCT) — Capital Reinvestment Ratio

Latest as of June 2023: 0.01x

Arcturus Therapeutics Holdings Inc (ARCT) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow ($50.81 Million) in capital expenditures ($354.00K). Check Arcturus Therapeutics Holdings Inc (ARCT) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$50.81 Million

USD

Capital Expenditures

$354.00K

USD

Data as of

Jun 2023

Most recent filing

Arcturus Therapeutics Holdings Inc Capital Reinvestment Ratio (2022–2022)

This chart tracks Arcturus Therapeutics Holdings Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Arcturus Therapeutics Holdings Inc (ARCT) cash flow conversion.

Annual Capital Reinvestment Ratio for Arcturus Therapeutics Holdings Inc (2022–2022)

Year-by-year Capital Reinvestment Ratio for Arcturus Therapeutics Holdings Inc from 2022 to 2022. See Arcturus Therapeutics Holdings Inc (ARCT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2022	0.24x	$31.99 Million	$7.73 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow